Ann: Quarterly Cash Flow and Summary of Activities, page-42

Justaguy In a teleconference a few months back IME's management explained that getting FDA approval and having soft launches in the USA and Oz was more about assisting with making it easier to win contracts in South America. They realised their resources were not sufficient to really tackle the USA and Oz. Maybe those plans have changed since, hence the CR.......though I hope not. Look back through some posts and questions raised by Composer and the replies, as a few were on the teleconference were this was discussed.